Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogs stable to phosphodiesterase hydrolysis

Authors:
  • VMVictor E. Marquez
    Victor E. Marquez
  • CTChristopher K. H. Tseng
    Christopher K. H. Tseng
  • GGGulilat Gebeyehu
    Gulilat Gebeyehu
  • DCDavid A. Cooney
    David A. Cooney
  • GAGurpreet S. Ahluwalia
    Gurpreet S. Ahluwalia
  • MDMaha Dalal
    Maha Dalal
  • RFRichard W. Fuller
    Richard W. Fuller
  • YWYvonne A. Wilson
    Yvonne A. Wilson
  • DJDavid G. Johns
    David G. Johns
Publisher website
Google Scholar
Abstract
Thiazole-4-carboxamide adenine dinucleotide (TAD), the active metabolite of the oncolytic C-nucleoside tiazofurin (TR), is susceptible to phosphodiesteratic breakdown by a unique phosphodiesterase present at high levels in TR-resistant tumors. Since accumulation of TAD, as regulated by its synthetic and degradative enzymes, appears to be an important determinant for sensitivity to the drug, a series of hydrolytically resistant phosphonate analogues of TAD were synthesized with the intent of producing more stable compounds with an ability to inhibit IMP dehydrogenase equivalent to TAD itself. Isosteric phosphonic acid analogues of TR and adenosine nucleotides were coupled with activated forms of AMP and TR monophosphate to give dinucleotides 2 and 4. Coupling of protected adenosine 5'-(alpha, beta-methylene)diphosphate with isopropylidene-TR in the presence of DCC afforded compound 3 after deprotection. These compounds are more resistant than TAD toward hydrolysis and still retain potent activity against IMP dehydrogenase in vitro. beta-Methylene-TAD (3), the most stable of the TAD phosphonate analogues, produced a depletion of guanine nucleotide pools in an experimentally induced TR-resistant P388 tumor variant that was superior to that obtained with TR in the corresponding sensitive line.